Ampersand Capital Partners
Boston, USA · Growth
Their stated focus (public profile)
Ampersand Capital Partners is a private equity firm dedicated to healthcare and life sciences, making minority and majority equity investments in growth-oriented life sciences companies with revenue between $10–100 million and positive EBITDA. The firm focuses on key life sciences sub-segments including laboratory products, laboratory services, contract manufacturing, pharma services, and specialty products. Ampersand partners closely with founders and leadership teams, often serving as the first institutional investor, and drives value through organic growth, M&A strategies, and buy-and-build approaches.
Stages: Growth
Sectors: Healthtech, Life sciences, Manufacturing
Check size: $10 to $100 million of equity
On file: 40 companies on record
Website: ampersandcapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.